Therapeutic Plasma Exchange: Indications and Outcomes. Single-Center Registry

##plugins.themes.bootstrap3.article.main##

  •   Fakhriya Alalawi

  •   Ayman Aly Seddik

  •   Kashif Gulzar

  •   Marwa Tagelsir Ahmed

  •   Dileep Kovilazhikam

  •   Lalimole Sony

  •   Amna Alhadari

Abstract

Introduction: Therapeutic plasma exchange is used to manage immune-mediated diseases as early as 1970th. Nevertheless, the evidence beyond the therapeutic indication is still anecdotal and depends on observational data and national registries from different parts of the world. Aim of the Study: To review the use of therapeutic plasma exchange (TPE) to manage different conditions in the Dubai Hospital-nephrology department and benchmark against standard indications categories by American Society of Apheresis (ASFA) guidelines.


Methods: The study included all adult patients who performed TPE in Dubai Hospital during 24 months period from January 2017 until December 2019. Patient demographics, indications, anticoagulation used, the number of sessions, duration of hospitalization, ICU admission, mortality outcome, and occurrence of procedure-related complications were included.


Results: During the 24 months, 142 TPE sessions were performed for 33 registered patients (an average of 4.3 sessions/patient). The most common indications for TPE use in our registry were nephrology-related indications in 119 sessions (85%), while non-nephrology indications contributed for 21 sessions (15%). Among Nephrology related Indications, Thrombotic Thrombocytopenic purpura was the most common indication (47.8%), followed by post kidney transplantation (21%), while non-Nephrology-related indications were mainly for pancreatitis with Hypertriglyceridemia (9.2%). Complications arose in 2 sessions (1.4%), and mortality occurred in one (3%) critically ill patient related to non-procedure consequences and the severity of the underlying disease.


Conclusion: Our registry data confirm the safety of therapeutic plasma exchange in a professional, well-equipped nephrology setting when used for proper evidence-based indications with a lower rate of morbidity and mortality.


Keywords: Albumin, anticoagulation, fresh frozen plasma (FFP), therapeutic plasma exchange (TPE), thrombotic thrombocytopenic purpura (TTP)

References

Kaplan AA, Halley SE. Plasma exchange with a rotating filter. Kidney International. 1990; 38(1): 160-6.

Kaplan AA. Therapeutic plasma exchange: a technical and operational review. Journal of Clinical Apheresis. 2013; 28(1): 3-10.

Okafor C, Ward DM, Mokrzycki MH, Weinstein R, Clark P, Balogun RA. Introduction and overview of therapeutic apheresis. Journal of Clinical Apheresis. 2010; 25(5): 240-9.

Johnson JP, Moore Jr J, Austin HA, Balow TT. Antonovych, and CB Wilson. Therapy of anti-glomerular basement membrane antibody disease: analysis of prognostic significance of clinical, pathologic and treatment factors. Medicine. 1985; 64: 219-27.

Lewis EJ, Hunsicker LG, Lan SP, Rohde RD, Lachin JM. A controlled trial of plasmapheresis therapy in severe lupus nephritis. New England Journal of Medicine. 1992; 326(21): 1373-9.

McLeod BC, Wu KK, Knospe WH. Plasmapheresis in thrombotic thrombocytopenic purpura. Archives of Internal Medicine. 1980; 140(8): 1059-60.

Rock GA, Shumak KH, Buskard NA, Blanchette VS, Kelton JG, Nair RC, et al. Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. New England Journal of Medicine. 1991; 325(6): 393-7.

Hutchison CA, Cockwell P, Reid S, Chandler K, Mead GP, Harrison J, Efficient removal of immunoglobulin free light chains by hemodialysis for multiple myeloma: in vitro and in vivo studies. Journal of the American Society of Nephrology. 2007; 18(3): 886-95.

Madore F, Lazarus JM, Brady HR. Therapeutic plasma exchange in renal diseases. Journal of the American Society of Nephrology. 1996; 7(3): 367-86.

Matalon A, Markowitz GS, Joseph RE, Cohen DJ, Saal SD, Kaplan B, et al. Plasmapheresis treatment of recurrent FSGS in adult renal transplant recipients. Clinical Nephrology. 2001; 56(4): 271-8.

Mokrzycki MH, Kaplan AA. Therapeutic plasma exchange: complications and management. American Journal of Kidney Diseases. 1994; 23(6): 817-27.

American Medical Association Panel. Current status of therapeutic plasmapheresis and related techniques: report of the AMA panel on therapeutic plasmapheresis. JAMA. 1985; 253: 819-25.

Schmidt JJ, Asper F, Einecke G, Eden G, Hafer C, Kielstein JT. Therapeutic plasma exchange in a tertiary care center: 185 patients undergoing 912 treatments-a one-year retrospective analysis. BMC Nephrology. 2018; 19(1): 1-7.

Walters G. Role of therapeutic plasmapheresis in ANCA-associated vasculitis. Pediatric Nephrology. 2016; 31(2): 217-25.

Korkmaz S, Keklik M, Sivgin S, Yildirim R, Tombak A, Kaya ME, Therapeutic plasma exchange in patients with thrombotic thrombocytopenic purpura: a retrospective multicenter study. Transfus Apher Sci. 2013; 48(3): 353-8.

Prendecki M, Pusey C. Plasma exchange in anti-glomerular basement membrane disease. La Presse Médicale. 2019; 48(11): 328-37.

Xie P, Tao M, Peng K, Zhao H, Zhang K, Sheng Y, et al. Plasmapheresis therapy in kidney transplant rejection. Blood Purification. 2019; 47(1-3): 73-84.

Padmanabhan A, Connelly‐Smith L, Aqui N, Balogun RA, Klingel R, Meyer E, et al. Guidelines on the use of therapeutic apheresis in clinical practice–evidence‐based approach from the Writing Committee of the American Society for Apheresis: the eighth special issue. Journal of Clinical Apheresis. 2019; 34(3): 171-354.

Truong AD, Auld SC, Barker NA, Friend S, Wynn AT, Cobb J, et al. Therapeutic plasma exchange for COVID-19-associated hyperviscosity. Transfusion. 2021; 61(4): 1029-1034.

Gucyetmez B, Atalan HK, Sertdemir I, Cakir U, Telci L. Therapeutic plasma exchange in patients with COVID-19 pneumonia in intensive care unit: a retrospective study. Critical Care. 2020; 24: 1-4.

Patidar GK, Land KJ, Vrielink H, Rahimi-Levene N, Dann EJ, Al-Humaidan H, et al. Understanding the role of therapeutic plasma exchange in COVID-19: preliminary guidance and practices. Vox Sang. 2021; 116(7): 798-807.

Gilcher RO, Smith JW. Apheresis: Principles and technology of hemapheresis. Rossi's Principles of Transfusion Medicine. 2009.

Assessment of plasmapheresis: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology. 1996; 47: 840 –43.

Joan C, Gloria C, Bienvenida A, Antonio B, Ana GC, Miguel L. Efficacy and safety of plasma exchange: an 11-year single-center experience of 2730 procedures in 317 patients. Transfusion and Apheresis Science. 2014; (51): 209-214.

Pene F, Vigneau C, Auburtin M, Moreau D, Zahar JR, Coste J, et al. Outcome of severe adult thrombotic microangiopathies in the intensive care unit. Intensive Care Medicine. 2005; 31(1): 71-78.

Darmon M, Azoulay E, Thiery G, Ciroldi M, Galicier L, Parquet N, et al. Time course of organ dysfunction in thrombotic microangiopathy patients receiving either plasma perfusion or plasma exchange. Critical Care Medicine. 2006; 34(8): 2127-33.

Carrillo IG, Demelo-Rodriguez P, Ferrero ML, Anaya F. Double filtration plasmapheresis in the treatment of pancreatitis due to severe Hypertriglyceridemia. Journal of Clinical Lipidology. 2015; 9(5): 698-702.

Kyriakidis AV, Raitsiou B, Sakagianni A, Harisopoulou V, Pyrgioti M, Panagopoulou A, et al. Management of acute severe hyperlipidemic pancreatitis. Digestion. 2006; 73(4): 259-64.

Syed H, Bilusic M, Rhondla C, Tavaria A. Plasmapheresis in the treatment of hypertriglyceridemia-induced pancreatitis: A community hospital's experience. J Clin Apher. 2010; 25(4): 229-34.

Chang CT, Tsai TY, Liao HY, Chang CM, Jheng JS, Huang WH, et al. Double filtration plasma apheresis shortens hospital admission duration of patients with severe hypertriglyceridemia-associated acute pancreatitis. Pancreas. 2016; 45(4): 606-12.

Aguirre-Valencia D, Naranjo-Escobar J, Posso-Osorio I, Macía-Mejía MC, Nieto-Aristizábal I, Barrera T, et al. Therapeutic Plasma Exchange as Management of Complicated Systemic Lupus Erythematosus and Other Autoimmune Diseases. Autoimmune Dis. 2019; 2019: 5350960.

Pons-Estel GJ, Salerni GE, Serrano RM, Gomez-Puerta JA, Plasin MA, Aldasoro E, et al. Therapeutic plasma exchange for the management of refractory systemic autoimmune diseases: report of 31 cases and review of the literature. Autoimmunity Reviews. 2011; 10(11): 679-84.

Kim M, Martin ST, Townsend KR, Gabardi S. Antibody‐mediated rejection in kidney transplantation: a review of pathophysiology, diagnosis, and treatment options. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy. 2014; 34(7): 733-44.

Gubensek J, Buturovic-Ponikvar J, Kandus A, Arnol M, Kovac J, Marn-Pernat A, et al. Plasma exchange and intravenous immunoglobulin in the treatment of antibody-mediated rejection after kidney transplantation: a single-center historic cohort study. Transplant Proc. 2013; 45(4): 1524-7.

Gubensek J, Buturovic‐Ponikvar J, Kandus A, Arnol M, Lindic J, Kovac D, et al. Treatment of Antibody‐Mediated Rejection After Kidney Transplantation–10 Years' Experience With Apheresis at a Single Center. Therapeutic Apheresis and Dialysis. 2016; 20(3): 240-5.

Brown CM, Abraham KA, O'Kelly P, Conlon PJ, Walshe JJ. Long-term experience of plasmapheresis in antibody-mediated rejection in renal transplantation. Transplant Proc. 2009; 41(9): 3690-2.

Cravedi P, Kopp JB, Remuzzi G. Recent progress in the pathophysiology and treatment of FSGS recurrence. American Journal of Transplantation. 2013; 13(2): 266-74.

Ponticelli C, Glassock RJ. Posttransplant recurrence of primary glomerulonephritis. Clinical Journal of the American Society of Nephrology. 2010; 5(12): 2363-72.

Kashgary A, Sontrop JM, Li L, Al-Jaishi AA, Habibullah ZN, Alsolaimani R, et al. The role of plasma exchange in treating post-transplant focal segmental glomerulosclerosis: A systematic review and meta-analysis of 77 case-reports and case-series. BMC Nephrol. 2016; 17(1): 104.

McLeod BC. Therapeutic apheresis: use of human serum albumin, fresh frozen plasma and cryosupernatant plasma in therapeutic plasma exchange. Best Pract Res Clin Haematol. 2006; 19(1): 157-67.

Shemin D, Briggs D, Greenan M. Complications of therapeutic plasma exchange: a prospective study of 1,727 procedures. J Clin Apher. 2007; 22(5): 270-6.

##plugins.themes.bootstrap3.article.details##

How to Cite
Alalawi, F., Aly Seddik, A., Gulzar, K., Ahmed, M. T., Kovilazhikam, D., Sony, L., & Alhadari, A. (2022). Therapeutic Plasma Exchange: Indications and Outcomes. Single-Center Registry. European Journal of Clinical Medicine, 3(1), 31–36. https://doi.org/10.24018/clinicmed.2022.3.1.163

Most read articles by the same author(s)